Mapping the tandem mass spectrometric characteristics of 







The final version was published in: 
 






Mapping the tandem mass spectrometric characteristics of  













1) ELTE Eötvös Loránd University, Doctoral School of Chemistry,  
Budapest, Hungary 
2) MTA-ELTE Research Group of Peptide Chemistry, Hungarian Academy of Sciences, 
ELTE Eötvös Loránd University, Budapest, Hungary 
3) MS Proteomics Research Group, Research Centre for Natural Sciences, 
Hungarian Academy of Sciences, Budapest, Hungary 
4) ELTE Eötvös Loránd University, Department of Organic Chemistry,  
Budapest, Hungary 




Gitta Schlosser, PhD 
ELTE Eötvös Loránd University, Department of Analytical Chemistry,  
Pázmány Péter sétány 1/A, 1117, Budapest, Hungary 
E-mail: sch@chem.elte.hu 




RATIONALE Protein citrullination (deimination) is a post-translational modification of 
proteins converting arginine(s) to citrulline(s). “Overcitrullination” could be associated with 
severe pathological conditions. Mass spectrometric analysis of modified proteins is hindered 
by several problems. A comprehensive study of fragmentation of deiminated peptides is not 
yet available. In this paper we have made an attempt to describe the characteristics of these 
processes, based on the studies of epitope model oligopeptides derived from clinically 
relevant proteins. 
METHODS Solution of purified model peptides containing either one or two citrulline 
residues as well as their native variants were injected directly to the electrospray source of a 
high accuracy and resolution quadrupole-time of flight instrument and were analysed by 
tandem mass spectrometry using low-energy collision induced dissociation.  
RESULTS Loss of isocyanic acid from citrulline residues is a preferred fragmentation route 
for deiminated peptides, which yields ornithine residues in the sequence. However, 
simultaneous detection of both the isocyanic acid loss and sequence fragments is often 
compromised. A preferential cleavage site was observed between citrulline and any other 
following amino acids yielding intensive complementary b and y type ions. Also, citrulline 
positioned at the C-termini displays a preferential cleavage N-terminal to this residue yielding 
characteristic y1 ions. These phenomena are described here for the first time and are referred 
to as the “citrulline effect”. 
CONCLUSIONS We found that the citrulline effect is very pronounced and could be used as 
a complementary tool for the confirmation of modification sites in addition to losses of 
isocyanic acids from the protonated molecules or from fragment ions. Low collision energy 
applied to peptide ions having partially mobile protons reveal the site of modification by 
generating specific and intensive fragments of the sequence. On the other hand, fragmenting 
parent ions with mobile protons usually allow full sequence coverage, although citrulline-
specific fragments may exhibit lower intensities compared to other fragments. 
 







Protein citrullination (deimination) is a post-translational modification of proteins through 
which arginine residues (Arg, R) in certain sequentially well-defined positions are converted 
to citrulline (Cit, X)
1
 (Figure 1). Citrulline is a genetically non-coded amino acid and has a 
neutral side chain under physiological conditions. Deimination is catalysed by the peptidyl-
arginine deiminase (PAD) enzymes and results in a monoisotopic mass increment of 0.9840 
Da, isobaric with deamidation of asparagine and glutamine residues.  
‘Overcitrullination’ is associated with several pathological conditions such as autoimmune 
diseases
2
, numerous neurodegenerative diseases
3,4,5
 and even tumour growth
6
. Nevertheless, 
only immunological (functional) or mass spectrometric (structural) methods could be 
sensitive and specific enough for the detection of the modified species in complex biological 
samples due to the low abundance of deiminated proteins
7
. Nowadays, immunodetection is 
used as a routine method to verify the presence of this post-translational modification in 
proteins e. g. for rheumatoid arthritis
8
, however this approach is unable to determine the 
modification site. Locating the site of deimination is only possible with high resolution and 
high mass accuracy tandem mass spectrometry which lacks high specificity and therefore still 
needs improvement
9
. In the last few years, several methods have been developed to improve 
the detection of deiminated polypeptides, including a specific and sensitive reaction with the 
modified residues
10
 or the enrichment of citrullinated peptides on beads with phenylglyoxal 
derivatives
11,12
. Detection of modified proteins is a key step for the diagnosis, monitoring and 
staging of diseases associated with faulty deimination. 
A selective loss of isocyanic acid (HNCO) has been reported for a few citrulline containing 
model peptides using collision induced dissociation (CID)
13
 (Figure 2A). Creese et al. utilised 
the loss of HNCO for selecting deiminated peptides in a complex sample and further 




However, the behaviour of citrulline containing peptides upon CID has not been a target for 
systematic investigation so far. Our study is therefore focused on unravelling the major 
characteristics of fragmentation of citrullinated peptides. To obtain clinically relevant results 
we selected protein epitopes which play role in rheumatoid arthritis (RA)
15-18
. RA is a 
systemic autoimmune disease in which citrullinated autoantigens are generated and are 
recognised by antibodies, resulting in a chronic inflammatory condition, destroying joints and 
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causing severe pain to the patients
19
. For these studies several oligopeptide variants were 
synthesised and analysed to get insight into the major characteristics of CID fragmentation of 
deiminated peptides. 
Materials. Formic acid, distilled water and acetonitrile for MS analyses were from VWR 
(Radnor, PA, USA). Leu-enkephalin was used as a reference material for accurate mass 
measurements. 
Methods. Model peptides GER, TRGRS, VERHQS, GPRVVER and GYRARPAK were 
selected from the epitope regions of fibrin, filaggrin and collagen, which are substrates of 
PADs and are involved in rheumatoid arthritis
15-18
. These model peptides represent a variety 
of amino acids, e.g. basic, acidic, aromatic and neutral side chains. All peptides were 
synthesised with free N- and C-termini by a Syro2000 peptide synthesiser using Fmoc-
t
Bu 
strategy. Native Arg containing peptides were prepared along with their Cit containing 
variants by systematic replacement of Arg to Cit. Ala-containing peptides were also 
synthesised as control compounds by substituting all arginines with Ala. Full list of the 
peptides is shown in Table 1.  
Peptides were purified by preparative RP-HPLC (Phenomenex Luna 250x10 mm C18 
column, 5 µm, 100 Å), with gradient elution (eluent ”A”: 0.1% (v/v) trifluoroacetic acid in 
water; eluent “B”: 0.1% (v/v) trifluoroacetic acid, 20% (v/v) water in acetonitrile; 0 min: 2% 
“B”, 2 min: 2% “B”, 30 min: 97% “B”). Peptides were freeze-dried and subsequently 
analysed by tandem mass spectrometry with a high mass accuracy and resolution Waters 
QTOF Premier hybrid mass spectrometer equipped with electrospray ionisation source (ESI). 
Samples were directly injected into the ESI source from a solvent mixture of acetonitrile-
water (1:1, v/v) with 0.1 % formic acid content at a flow rate of 10 μL/min. 
 
Results 
This research is focused on the collision induced dissociation (CID) of oligopeptides 
containing citrulline residues to identify their preferred fragmentation routes. For this, 
fragmentation characteristics were compared by using oligopeptides and their substituted 
analogues of 3-8 amino acid residues containing one or two arginines. In these compounds, 
Arg residues were replaced either by Cit or by Ala (Table 1). 
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Major fragmentation characteristics of the peptides can be well interpreted by the 
mobile proton theory
20
, which we find useful for Cit-peptides as well. Based on this, peptides 
could be categorised as having either 1) no mobile protons (where the number of arginines is 
equal to or greater than the number of ionising protons within the sequence), 2) partially 
mobile protons (where the number of ionising protons is greater than that of arginines but 
fewer than that of or equal to the overall basic residues and N-terminus) or 3) mobile protons 
(where the number of ionising protons is greater than that of the overall basic sites)
21
. It 
should also be noted that this categorisation is only for practical purposes and sometimes 
lower charge states are missing from the single stage MS spectra. This is the case for large 
non-tryptic peptides or the ones containing several slightly basic amino acids (His, Lys, Cit). 
Protons of peptide ions with low charge states in this category sometimes behave like as if 
they were non-mobile ones (e.g. the singly protonated GPXVVEX peptide, data not shown). 
We found that charge state distribution in single stage MS is altered and shifted to 
lower values by substituting Arg residues with Cit ones, suggesting the neutral characteristic 
of citrulline under electrospray ionization (Figure S1). This is in agreement with previous 
studies.
9
 In case of the pentapeptides, however, higher charge states were not necessarily 
absent, only less intensive, indicating that Cit could be partially charged under MS conditions 
at least for a limited number of peptides. On the other hand, Cit could be considered a neutral 
residue due to lack of proton sequestration ability in our MSMS experiments. 
Charge states of model peptides having no mobile protons usually tend to produce 
fragments corresponding to the neutral loss of isocyanic acid as base peak or as the second 
most intensive peak at low collision energies (Figure S2). HNCO loss of citrulline residues 
yields ornithines in the sequence. High intensity of HNCO loss can be explained by the proton 
sequestration of arginine residues disabling low-energy protons to migrate through the 
sequence inducing alternate decomposition pathways. Enhanced collision energy has a 
beneficial impact on generating sequence ions but along with hardly identifiable combinations 
of complex neutral losses. This latter feature was especially pronounced in case of the 
threonine containing pentapeptide series. It is, however, important to note that the intensities 
of parent ions having no mobile protons are usually low amongst peptides derived from 
enzymatic cleavage of proteins. 
Parent ions having partially mobile protons also show highly abundant loss of HNCO, 
often being base peaks at low energies (Figure 3C, Figure S3B). In these cases, the neutral 
loss of isocyanic acid was accompanied by highly abundant bx-yz products originated from a 
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preferential cleavage site that is C-terminal to Cit residues (Figure 3B, C, D). Preferential 
cleavage of the Cit-Aaa bond of peptides in gas phase is described here for the first time and 
termed citrulline effect. In our opinion, cleavage of the Cit-Aaa bond is facilitated by the 
formation of ornithine (Orn) residues during the neutral loss of HNCO from citrulline. The 
following mechanism could explain the process: the peptide containing citrulline(s) is first 
protonated on one of its basic sites. After collision induced excitation, the proton migrates to 
the δ-NH-group initiating the dissociation process. The reaction leads to a protonated 
peptidyl-Orn residue (Figure 2A)
13
. In the second step, a favourable, six-membered lactam 
ring is formed (Figure 2B) from Orn. Facile cleavage of residues C-terminal to Orn within 
peptides in gas phase has been previously described by McGee and McLuckey
22
.  
Enhanced collision energy results in the appearance of other informative sequence fragments, 
as well as their ‘ornithinated’ variants by HNCO loss while the peaks corresponding to the 
citrulline effect remain very intensive. We also found (Figure S3) that proline effect was 
inferior to citrulline effect, similarly to previously described results for ornithine containing 
peptides
22
. The only exception was peptide GYXARPAK, in which a more preferred cleavage 
at YX peptide bond was observed leading to the intensive peak pair of b2 and a2 fragment ions 
(Figure S3). 
If Cit is in an (n-1) position relative to the C-terminus, intensity of an y1 ion will be also 
increased. The pentapeptide model set based on the TRGRS peptide sequence is shown on 
Figure S4 as an example. Y1 ions are characteristic to tryptic peptides and confirm the identity 
of C-terminal Arg or Lys. These important fragment ions are also present in the spectra of 
peptides containing C-terminal Cit with high intensities and are generally accompanied by 
NH3 loss (Figure 3B, D).  
Peptide charge states having mobile protons also display the loss of HNCO, however 
backbone fragmentation becomes a competitive pathway. The former process is therefore less 
pronounced. Fragment ions show losses of HNCO as well. In these cases, complementary b/y 
fragment ions corresponding to citrulline effect may not have significantly higher intensities 
than other ones. Sequence fragments which are not present in the tandem mass spectra of 
charge states possessing partially mobile protons could also appear for alternative charge 
states having mobile protons.  
Most intensive fragment ions of the peptides and ions with HNCO loss are summarised in 





Although several methods have been developed for the analysis of citrullination, a 
comprehensive study of fragmentation characteristics at the peptide level is still not available. 
In this work, we identified basic principles connected to the MSMS behaviour of peptides 
containing citrulline(s) to improve mass spectrometry based detection of deimination in terms 
of specificity, reliability and speed in the future.  
Model peptides GER, TRGRS, VERHQS, GPRVVER, GYRARPAK and all their possible 
deiminated variants were synthesised by solid phase peptide synthesis (Table 1). Control 
peptides were also synthesised by systematic replacement of Cit residues by Ala. The peptides 
selected are corresponding to epitope regions of proteins (collagen, filaggrin, fibrin) which are 
targets of immunorecognition in rheumatoid arthritic joint tissues. Some of the peptides 
mimic cleavage results by trypsin or LysC (Arg or Lys residues at the C-termini).  
Our results were in good agreement with the mobile proton hypothesis, described previously 
for general interpretation of peptide fragmentation by tandem mass spectrometry
20
. 
We observed that peptide charge states having partially mobile protons provide a pronounced 
intensity of fragments corresponding to the Cit-Aaa cleavage at low energy CID leading to b 
and/or y type ions. This feature is described here for the first time and it may also be observed 
for parent ions with fully mobile protons. A similar phenomenon was described previously
22
 
for Orn-Aaa amide bond in Orn-containing peptides. We suppose that the isocyanic acid loss 
from Cit residues, resulting in a newly generated Orn residue in the sequence using CID, 
explains the facile Cit-Aaa bond cleavage (Figure 2).  
Loss of isocyanic acid is also a very selective reaction of citrulline containing peptides, which 
can be observed from parent ions and for fragment ions as well. Sequence coverage could also 
be increased – to a limited extent – by raising collision energies without losing valuable peaks 
corresponding to citrulline effect. In our experiments, peptides were also analysed on an ion 
trap instrument and the compounds showed essentially the same fragmentation profiles 
indicating the robustness of the method. An example for low energy CID tandem mass spectra 
acquired on ion trap is shown on Figure S5. 
Our results indicated that y1 ions of Cit are abundantly present due to the cleavage at Aaa-Cit, 
if Cit was located at the C-terminus (Figure 3B, D). This is also an important feature, 
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especially given the fact that the first MS-grade mutant enzyme capable of cleaving at the C-
terminus of has been developed recently
23
. 
Based on our experiments, the major factors effecting favoured fragmentation routes for 
deiminated peptides could be outlined. These pathways, such as the neutral loss of isocyanic 
acid, conventional sequential fragmentation and specific sequential fragmentation pathways 
(e.g. citrulline effect) could be elucidated by the mobile proton theory. Increasing proton 
mobility decreases the intensities of peaks corresponding to the loss of HNCO as in case of 
other types of neutral losses. On the other hand, citrulline effect may remain intensive in case 
of higher proton mobilities or at elevated collision energies. Thus, utilisation of citrulline 
effect along with the loss of HNCO could greatly contribute to a more reliable identification 
and sequencing of deiminated peptides. 
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360,1757 360,1755 -0,6 
GEX Cit-analogue 361,1597 361,1598 0,3 
GEA Ala-analogue 275,1117 275,1118 0,4 
TRGRS filaggrin(311-315) 575,3140 575,3148 1,4 
TRGXS Cit-analogue 576,2980 576,2978 -0,3 
TXGRS Cit-analogue 576,2980 576,2981 0,2 
TXGXS Cit-analogue 577,2820 577,2813 -1,2 
TAGAS Ala-analogue 405,1860 405,1863 0,7 
VERHQS fibrin α40-45 754,3722 754,3738 2,1 
VEXHQS Cit-analogue 755,3562 755,3563 0,1 
VEAHQS Ala-analogue 669,3082 669,3073 -1,3 
GPRVVER fibrin α36-42 811,4664 811,4693 3,6 
GPRVVEX Cit-analogue 812,4504 812,4526 2,7 
GPXVVER Cit-analogue 812,4504 812,4489 -1,8 
GPXVVEX Cit-analogue 813,4345 813,4353 1,0 
GPAVVEA Ala-analogue 641,3384 641,3383 -0,2 
GYRARPAK fibrin β70-77 917,5195 917,5220 2,7 
GYRAXPAK Cit-analogue 918,5035 918,5075 4,4 
GYXARPAK Cit-analogue 918,5035 918,5067 3,5 
GYXAXPAK Cit-analogue 919,4876 919,4907 3,4 





Table 2 Fragmentation of the peptides. Fragments are generated from partially mobile parent 
ions. Fragments between 1-5 % of the base peak intensity are in brackets. Peptides containing 






Loss of HNCO detected 
GER b2 y1, y2 - 
GEX b2 y1, (y2) MH
+, y1 
GEA b2 y1, (y2) - 
TRGRS a1, b2, b3 y1, y2, y3 - 
TRGXS a1, b2, b3, b4 y1 (b4) 
TXGRS a1, b2 y1, y3, y4 b2, (y4) 
TXGXS b2, b3, b4 (y1), y2, y3, (y4) MH
+ (2x), b2, b4 (2x), y3 
TAGAS b2, b3, b4 y1, y2, y3, y4 - 
VERHQS a1, b2, b3, b4, (b5) y1, y2, y3, y4, y5 - 
VEXHQS a1, b2, b3, b4, b5 y2, y3, y4, (y5) MH
+, b3, b4, b5, y4 
VEAHQS a1, b2, (b3), (b4), (b5) (y1), y2, (y3), y4, y5 - 
GPRVVER b2, b3, b4, (b5) y1, y2, y3, y4 - 
GPRVVEX (b2), b3, b4, b5, b6 y1, y2, (y3) MH
2+ 
GPXVVER b2, b3, b4 y1, y2, y3, y4, y5 b3, b4, y5 
GPXVVEX (b2), b3, b4, b5, b6 y1, y2, y3, y4 MH
2+, MH2+(2x), (b4), b5, b6, (y3) 
GPAVVEA (b2), b3, b4, b5, b6 y2, y3, y4 - 
GYRARPAK a2, b3, (b4), (b5), (b6) y1, y2, y3, (y5) - 
GYRAXPAK a2, (b3), (b4), b5, b7 y1, y2, y3 MH
2+, b5, b7 
GYXARPAK a2, b3, (b4), b5, b7 
y1, (y2), y3, y4, y5, y6, 
y7
2+ 
MH+, (b3), (b4), (b5), (b7), y6 
GYXAXPAK a2, b3, b4, b5, (b7) y1, (y2), y3, y4, y5, y6 
MH2+ (2x), (b3), (b4), (b5), (y4), y5, (y6), 
(b7) 





Figure 1 Protein deimination (citrullination) by the peptidyl arginine deiminase (PAD) 
enzymes altering physico-chemical properties of the substrates. 
Figure 2 Proposed mechanism for citrulline effect leading to facile cleavage C-terminal to 
citrulline residues for gas phase protonated peptides. First step: loss of isocyanic acid 
(HNCO) characteristic to citrulline residues, leading to an ornithine residue (A)
8
. Second step: 
cleavage of the Orn-Aaa bond (B)
12
. 
Figure 3 Tandem mass spectra of the heptapeptide model series. Triply protonated 
GPRVVER fragmented at a collision energy of 7.5 eV (A), doubly protonated GPRVVEX at 
10.0 eV (B), doubly protonated GPXVVER at 10.0 eV (C) and doubly protonated 
GPXVVEX at 7.5 eV (D). HNCO (@), NH3 (*), H2O (°) and CO2 (#) side chain losses are 
also indicated. Charge states and collision energies were tuned that the protonated molecules, 
the sequence ions and isocyanic acid loss could be detected with a reasonable yield. It should 
be noted that the +2 ion of peptide GPRVVER at a collision energy of 10.0 eV remained 
intact due to the proton sequestration of Arg. Cit-containing peptides produce abundant peaks 
corresponding to Cit-Aaa cleavages due to the citrulline effect with charge retention on the 





Figure S1 Ion trap single stage mass spectra demonstrating the charge shift of Cit-containing 
peptide ions to lower values compared to their native variants’. Note that peptide ion 
[M+3H]
3+
 is completely missing from the spectrum of VEXHQS. Spectra were acquired on a 
Bruker Esquire 3000+ mass spectrometer. 
Figure S2 Tandem mass spectrum of the singly protonated TXGRS peptide, a typical parent 
ion lacking mobile protons. Loss of HNCO is indicated by an ‘at’ sign (@). In the absence of 
other available fragmentation pathways, the protonated molecule displays abundant loss of 
HNCO besides other minor non-sequential neutral losses. 
Figure S3 Tandem mass spectra of the octapeptide series. Triply protonated GYRARPAK at 
a collision energy of 10.0 eV (A), doubly protonated GYRAXPAK at 15.0 eV (B), doubly 
protonated GYXARPAK at 15.0 eV (C) and doubly protonated GYXAXPAK at 10.0 eV (D). 
Neutral losses of HNCO (@), NH3 (*), H2O (°) and CO2 (#) are indicated. Note that 
fragments corresponding to a Cit-Ala and Cit-Pro cleavage are usually highly intensive. 
Comparing B and C implies that the so-called Pro effect is inferior to Cit effect. However, in 
case of C, the cleavage of Tyr-Cit amide bond is preferred. 
Figure S4 Representation of citrulline effect for peptides TRGXS (A) and TXGRS (B). The 
Cit-Ser cleavage yields extraordinarily intensive b4-y1 ion pairs (A), while in case of TXGRS 
only the intensity of y3 is enhanced significantly due to the Cit-Gly cleavage (B).  
Figure S5 Ion trap tandem mass spectra of the heptapeptides. Triply protonated GPRVVER 
(A), doubly protonated GPRVVEX (B), doubly protonated GPXVVER (C) and doubly 
protonated GPXVVEX (D) were all fragmented at a collisional amplitude of 1.0 V. Spectra 
were acquired on a Bruker Esquire 3000+ mass spectrometer. 
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